Evidence map›Paper›PMID 40386255›Full record

ArticleTranslational cancer research2025

Elevated levels of total cholesterol and high-density lipoprotein cholesterol are associated with better prognosis in patients with lung adenocarcinoma: a retrospective cohort study.

Zhupeng Li, Jianfeng Xu, Jiacheng Wu, Junqing Zhou, Haiyong Wang, Haixia Xu, Bin Wang, Jianyi Ding, Guangmao Yu, Peng Xu

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhupeng Li *Department of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Jianfeng Xu *Department of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Jiacheng Wu *Department of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Junqing ZhouDepartment of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Haiyong WangDepartment of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Haixia XuDepartment of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Bin WangDepartment of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Jianyi DingDepartment of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Guangmao YuDepartment of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.
Peng XuDepartment of Cardiothoracic Surgery, Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University, Shaoxing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As is well known, lipids play an important role in cellular metabolism and storage, and they have a significant impact on signal transduction during the growth and metastasis of cancer cells. Our study aimed to evaluate the role of the preoperative plasma lipid profile, including triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) in prognosis, and to develop nomograms to predict overall survival (OS) and disease-free survival (DFS) based on the preoperative plasma lipid profile for patients with lung adenocarcinoma (LUAD) after complete resection. Methods: Clinical data, including preoperative plasma profile levels, were retrospectively collected and reviewed in 304 patients with LUAD who underwent radical lung resection between 2016-2017. Approval of the study protocol was obtained from the Academic Ethics Committee of Shaoxing People's Hospital, and follow-up on all patients was completed in the clinic or by telephone. The OS and DFS were assessed by the Kaplan-Meier method and the Cox proportional hazards regression model. Clinicopathological factors and preoperative plasma lipid profile factors were integrated to construct nomograms. Calibration plots and concordance indexes (C-indexes) were used to evaluate the accuracy and discrimination of the models. Results: TC level was significantly related to the sex of the patient (P=0.001), history of smoking (P=0.04), and death (P=0.007), and the HDL-C level was significantly associated with sex (P=0.004), history of smoking (P=0.02), tumor recurrence (P=0.050), and death (P=0.002). TC ≤3.58 and HDL-C ≤1.01 were deemed as independent preoperative risk factors for OS, and HDL-C ≤1.01 was an independent preoperative risk factor for DFS. In the multivariate analyses involving OS and DFS, an increased TC level [hazard ratio (HR), 0.504; 95% confidence interval (CI): 0.324-0.782, P=0.002] was significantly associated with better OS. Additionally, a decreased HDL-C level was significantly associated with worse OS (HR, 0.665; 95% CI: 0.443-0.999, P=0.049) and DFS (HR, 0.619; 95% CI: 0.420-0.912, P=0.02). Preoperative plasma lipid profile factors were involved in constructing the nomograms for predicting 1-, 3-, and 5-year OS and DFS. The C-index of the final nomograms was higher than that of the tumor node metastasis (TNM) staging system for predicting OS (0.735 Conclusions: In patients with LUAD, increased TC levels may predict better OS, while decreased levels of HDL-C may predict worse outcomes for both DFS and OS. These findings may aid in the identification of high-risk patients and allow them to take necessary measures in advance.

Indexed as

lung adenocarcinoma (LUAD)Plasma lipid profileprognosis

Identifiers

PMID40386255
PMCPMC12079218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.